Previously, Ginsberg headed business development and strategic planning for SurModics, a publicly traded leader in the field of drug delivery. He also spent 15 years in the healthcare investment industry, during which time he was named a Wall Street Journal All-Star as Piper Jaffray’s lead biotechnology analyst.
Ginsberg acts as a reviewer for both the National Cancer Institute and the National Heart, Lung, and Blood Institute and is also a Chartered Financial Analyst and member of the CFA Institute. He earned an A.B. in Economics from Princeton University and an M.B.A. from the Tuck School of Business at Dartmouth College.
Prior to founding LRA, Cat spent 14 years at Burroughs Wellcome Co. (now GlaxoSmithKline), holding positions in clinical research, product management, managed care and corporate affairs. Actively involved in the pharmaceutical and biotechnology community, Cat has been an advisor to several firms in the RTP area and served on the Board of Gentris Corporation, a pharmacogenomics company.
In addition, Cat has maintained her focus on community service; she is the past Board Chair of the local area Chapter of the Cystic Fibrosis Foundation and continues to serve on the Board. She has also been involved with various strategic committees and/or volunteering roles for a an array of different organizations, including the Food Bank of Central and Eastern North Carolina, The Nature Conservancy, various animal rescue organizations and reading programs for disadvantaged children. Cat has previous work experience in behavioral and neurological toxicology at the National Institute of Environmental Health Sciences and academic training in pharmacy administration. She graduated with highest honors with a B.A. in psychology and is Phi Beta Kappa from the University of North Carolina at Chapel Hill.